The clinical trials below are available in the specialty you selected. Choose a different specialty.

A randomized, double-blind, placebo controlled study to assess the efficacy of LCQ908 on cardiovascular risk
This study is a proof of concept to determine if an investigational drug called LCQ908 can reduce triglyceride levels and lessen cardiovascular risk in people with cardiovascular disease. (REF# 35097)

A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects with Gout who have had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
To determine the efficacy of an investigational new medication, lesinurad, when used in combination with allopurinol compared to using allopurinol alone.
(REF# 37670)